Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry.
Tommes RiemerDominique BerndtAlexander BökerJosefine LehmannUlrike SchriflSaskia RauAnne RübsamAntonia M JoussenOliver ZeitzPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2023)
The data provides real-world evidence that there is loss of visual acuity and an increase in retinal edema after switching to bevacizumab. Thus, the assumption of free interchangeability cannot be confirmed in this cohort.